Telethon Kids Institute researchers are calling for participants for Australia’s first needle-free, gene-based COVID-19 vaccine study.
Led by The University of Sydney, Telethon Kids Institute is one of three locations chosen to participate in the COVALIA Booster Study evaluating the safety and effectiveness of the COVIGEN COVID-19 vaccine when given to healthy adults.
The COVIGEN vaccine uses a needle-free system that delivers genetic sequences of the COVID-19 spike protein through the skin to trigger an immune response. This technology is already being used for influenza vaccines in the USA and has been shown to be safe and stimulate protective antibodies.
Study researchers are currently seeking healthy adults aged 18 - 75 who have received their first two COVID-19 vaccines but have NOT received their booster dose.
Participants will be required to attend six clinic visits at Perth Children's Hospital and answer one phone survey.
If you would like to be involved in the COVALIA Study or would like more information, email vax4covid@telethonkids.org.au or call 0400 450 240.